Profil News

Our expert

Dr. Lars Bochmann

Executive Director Commercial Operations

June 24, 2025

Measuring Vascular Health in Clinical Trials: Flow-Mediated Dilation

Introducing Flow-Mediated Dilation At Profil, we continuously innovate and apply the cutting-edge methods in our clinical research to better understand and treat metabolic diseases. One such method

June 12, 2025

Studying Counterregulation with the Hypoglycemic Clamp

Introduction Hypoglycemic Clamp The hypoglycemic clamp is a gold-standard method for studying the body’s physiological response to low glucose levels. While often overshadowed by the more widely used

May 29, 2025

Continuous Glucose Monitoring for Improved Glycaemic Assessment

Introduction CGM Continuous Glucose Monitoring (CGM) has emerged as an indispensable tool in both the management and investigation of metabolic diseases. For scientists engaged in clinical research,

May 7, 2025

Advancing Liver Disease Research with Transient Elastography

Revolutionizing MASH and MASLD Clinical Trials with Transient Elastography At Profil, we're at the forefront of tackling metabolic diseases, focusing among others on Metabolic Associated Steatotic

April 23, 2025

Advancing Early-Phase Clinical Trials with Automated Euglycemic Glucose Clamps

Advancing Diabetes & Metabolic Research with Fully Automated Glucose Clamps At Profil, we set the gold standard in clamp methodology with ClampArt®, our proprietary fully automated glucose clamp

April 9, 2025

Exploring Metabolic Insights with Indirect Calorimetry

At Profil, our commitment to advancing metabolic health research is driven by our use of state-of-the-art technologies, such as Indirect Calorimetry. This highly accurate method is pivotal for

March 25, 2025

The Evolving Landscape of GLP-1 Agonists: What’s New, What’s Next

GLP-1 receptor agonists have gained immense popularity for their effectiveness in weight management, shifting from a mere treatment for diabetes to some of the most sought-after weight-loss drugs.

February 14, 2025

Enhancing Patient Recruitment for Diabetes and Obesity Trials: Profil’s Competitive Edge

In the realm of clinical research, particularly for metabolic disorders such as diabetes and obesity, the ability to efficiently recruit and retain patients is crucial to the success of any trial. In

January 16, 2025

Long-acting Amylin Analog Petrelintide, a Rising Star in Anti-Obesity treatment?

Introduction Obesity is a chronic complex disease contributing to the development of various obesity-related comorbidities, such as metabolic syndrome and dysfunction, type 2 diabetes, cardiovascular